People · Operator
Named in public records as an officer, director or promoter · active 2007–2018 · Investment Vehicle, Other Health Care, Pharmaceuticals, Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Helix Holdings I, LLC | — | Investment Vehicle | Series D+ | $235.0M | $764.9M | 2015 |
| Venus Concept Inc. | — | Other Health Care | Series C | $194.2M | $9.8M | 2011 |
| Portola Pharmaceuticals Inc | — | Pharmaceuticals | Series C | $158.1M | $315.8M | 2008 |
| Verinata Health Inc | — | Biotechnology | Series C | $56.2M | $30.7M | 2009 |
| Drais Pharmaceuticals Inc | — | Biotechnology | Series B | $20.0M | $793.8M | 2007 |
| Nugen Technologies Inc | — | Other Health Care | Series A | $11.2M | $124.7M | 2010 |
| Xios Therapeutics, Inc. | — | Pharma | Series A | $7.0M | $31.0M | 2015 |
JEFF BIRD at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JEFF BIRD on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng Kong | 1 | 16 |
| Craig Taylor | 1 | 13 |
| James Topper | 1 | 12 |
| James Wilson | 1 | 10 |
| Arnold Oronsky | 1 | 10 |
| Russell Hirsch | 1 | 10 |
| Frederic Moll | 1 | 10 |
| Noah Knauf | 1 | 9 |
| FRED MOLL | 1 | 8 |
| Jeffrey W. Bird | 1 | 6 |
| Jean George | 1 | 6 |
| Nicholas Galakatos | 1 | 6 |
| William Kelley | 1 | 6 |
| Bill Ericson | 1 | 5 |
| Farah Champsi | 1 | 5 |
| Jeffrey Bird | 1 | 5 |
| Juliet Tammenoms Bakker | 1 | 5 |
| Alan Frazier | 1 | 5 |
| Michael Hunkapiller | 1 | 4 |
| DOUG KELLY | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.